Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues - PubMed (original) (raw)

Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues

Y Noguchi et al. Jpn J Cancer Res. 1998 Mar.

Abstract

The objective of this study was to investigate the molecular weight (MW) and time-dependence of the phenomenon termed "the enhanced permeability and retention" (EPR) effect in solid tumor, in particular to determine and define the early phase accumulation of macromolecules in tumor and normal tissues and the relationship between blood concentration and tissue clearance. As a model, radioiodinated N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers of MW ranging from 4.5 K to 800 K were administered i.v. to mice bearing sarcoma 180 tumor. Within 10 min all HPMA copolymers accumulated effectively in the tumor regardless of MW (1.0-1.5% of injected dose per g of tumor). However, higher MW copolymers (> 50 K) showed significantly increased tumor accumulation after 6 h, while the lower MW copolymers (< 40 K) were cleared rapidly from tumor tissue due to rapid diffusion back into the bloodstream. Blood clearance was also MW-dependent; the lower MW copolymers displayed rapid clearance, with kidney radioactivity of the copolymers of MW < 20 K representing 24% of injected dose per g kidney at 1 min after i.v. administration. Within 10 min these copolymers passed through the kidney and were excreted in the urine. Higher MW copolymers consistently showed kidney levels of 3-5% dose per g kidney in the early phase with no time-dependent accumulation in kidney. There was also no progressive accumulation in muscle or liver, regardless of polymer MW. These results suggest the "EPR effect" in solid tumor primarily arises from in the difference in clearance rate between the solid tumor and the normal tissues after initial penetration of the polymers into these tissues.

PubMed Disclaimer

Similar articles

Cited by

References

    1. ) Konno , T. , Maeda , H. , Iwai , K. , Tashiro , S. , Maki , S. , Morinaga , T. , Mochinaga , M. , Hiraoka , T. and Yokoyama , I.Effect of arterial administration of high molecular weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report . Eur. J. Cancer Clin. Oncol. , 19 , 1053 – 1065 ( 1983. ). - PubMed
    1. ) Iwai , K. , Maeda , H. and Konno , T.Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X‐ray image . Cancer Res. , 44 , 2115 – 2121 ( 1984. ). - PubMed
    1. ) Konno , T. , Maeda , H. , Iwai , K. , Maki , S. , Tashiro , S. , Uchida , M. and Miyauchi , Y.Selective targeting of anti‐cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium . Cancer , 54 , 2367 – 2374 ( 1983. ). - PubMed
    1. ) Iwai , K. , Maeda , H. , Konno , T. , Matsumura , Y. , Yamashita , R. , Yamasaki , K. , Hirayama , S. and Miyauchi , Y.Tumor targeting by arterial administration of lipids: rabbit model with VX2 carcinoma in the liver . Anticancer Res. , 7 , 321 – 328 ( 1987. ). - PubMed
    1. ) Seymour , L. W. , Ulbrich , K. , Steyger , P. S. , Brereton , M. , Subr , V. , Strohalm , J. and Duncan , R.Tumour tropism and anticancer efficacy of polymer‐based doxorubicin prodrugs in the treatment of subcutaneous murine B16 F10 melanoma . Br. J. Cancer , 70 , 636 – 641 ( 1994. ). - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources